drugset / Trial / NCT01744314
Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma
Unknown
150 enrolled
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Patients who present to our institution with a traumatic injury to their elbow who need operative management will be randomized to one of two groups; a treatment arm and a control arm. The treatment arm will receive a three-week postoperative course of indomethacin while the control group will not. We will follow both groups to assess whether or not indomethacin prophylaxis affects the rate of heterotopic ossification.
Timeline
- Start
- 2012-11
- Primary completion
- 2019-11
- Completion
- 2019-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indomethacin | Small molecule | 25 mg | — |
| Background | Pantoprazole | Other / unclassified | 40 mg | — |
Indications
No indication recorded.